2021 - 2025

Augmenting the landscape of chimeric antigen receptor T-cell therapy

Expert Rev. Anticancer Ther. 2024 Jun3 27. doi: 10.1080/14737140.2024.2372330

Combinative workflow for mRNA vaccine development

Biochem Biophys Rep. 2024 June 25; 39: 101766. doi: 10.1016/j.bbrep.2024.101766.

Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field

Nat Commun. 2023 Nov 2; 14(1): 7028. doi: 10.1038/s41467-023-42732-2. 

Vaccine for leishmaniasis: New era of CRISPR generated Live attenuated dermotropic Leishmania

J Cell Mol Med. 2022 Mar 21; 1(1):12-16. doi: 10.46439/immunol.1.004.

Translational development of a tumor junction opening technology

Nature. 2022 May 11; Scientific Reports; Article number: 7753 (2022).

Development of a process for large scale production of PfRH5 in E. coli expression system.

Int J Biol Macromol. 2021 Aug 6;188:169-179. doi: 10.1016/j.ijbiomac.2021.08.014.

Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis.

Commun Biol. 2021 Jul; 4(1):929. doi: 10.1038/s42003-021-02446-x.

Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia.

Pediatr Blood Cancer. 2021; 3;e29046. doi:10.1002/pbc.29046.

Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities.

J Autoimmun. 2021; 118:102614. doi: 10.1016/j.jaut.2021.102614 

2016 - 2020

The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable.

J Biol Chem. 2020 Jan 10;295(2):403-414. doi: 10.1074/jbc.RA119.011268.

Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial.

NPJ Vaccines. 2018 Sep 28;3:48. doi: 10.1038/s41541-018-0083-3. eCollection 2018. PubMed PMID: 30302285; PubMed Central PMCID: PMC6162314.

The Leishmania donovani IMPACT-like protein possesses non-specific nuclease activity.

Int J Biol Macromol. 2018 Nov;119:962-973. doi: 10.1016/j.ijbiomac.2018.07.175.

Activation of HRI is mediated by Hsp90 during stress through modulation of the HRI-Hsp90 complex.

Int J Biol Macromol. 2018 Oct 15;118(Pt B):1604-1613. doi: 10.1016/j.ijbiomac.2018.06.204. Epub 2018 Jul 3. PubMed PMID: 30170366.

Elucidation of molecular mechanism of stability of the heme-regulated eIF2α kinase upon binding of its ligand, hemin in its catalytic kinase domain.

J Biomol Struct Dyn. 2018 Aug;36(11):2845-2861. doi: 10.1080/07391102.2017.1368417. Epub 2017 Sep 12. PubMed PMID: 28814160.

HRI, a stress response eIF2α kinase, exhibits structural and functional stability at high temperature and alkaline conditions.

Int J Biol Macromol. 2017 Feb;95:528-538. doi: 10.1016/j.ijbiomac.2016.11.071. Epub 2016 Nov 22. PubMed PMID: 27888007.

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.

NPJ Vaccines. 2017;2. pii: 10. doi: 10.1038/s41541-017-0011-y. Epub 2017 Apr 10. PubMed PMID: 28936360; PubMed Central PMCID: PMC5603302.

2011 - 2015

Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.

Malar J. 2015 Nov 9;14:443. doi: 10.1186/s12936-015-0972-0. PubMed PMID: 26552428; PubMed Central PMCID: PMC4640242.

Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria.

Front Microbiol. 2014 Jun 30;5:314. doi: 10.3389/fmicb.2014.00314. eCollection 2014. PubMed PMID: 25071730; PubMed Central PMCID: PMC4074990.

Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice.

Infect Immun. 2013 Mar;81(3):789-800. doi: 10.1128/IAI.01108-12.

Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies.

Infect Immun. 2012 Mar;80(3):1203-8. doi: 10.1128/IAI.05924-11. Epub 2012 Jan 3. PubMed PMID: 22215740; PubMed Central PMCID: PMC3294652.

Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the Nox4 promoter.

Free Radic Biol Med. 2011 Jun 15;50(12):1749-59. doi: 10.1016/j.freeradbiomed.2011.03.022. Epub 2011 Mar 26. PubMed PMID: 21443946; PubMed Central PMCID: PMC3454485.

TENECTASE®

Emgrast®

Assessing analytical comparability of biosimilars: GCSF as a case study

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 1;1032:165-171. doi: 10.1016/j.jchromb.2016.05.027.

GEMCOVAC®

GEMCOVAC®-19

Evaluation of self-amplifying mRNA platform for protein expression and genetic stability: Implication for mRNA therapies

Biochem Biophys Res Commun. 2023 Nov 5; 680: 108-118. doi: 10.1016/j.bbrc.2023.09.016.

 

GEMCOVAC®-OM

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

Nat Med. 2024 Apr 18; 30, 1363–1372. doi: 10.1038/s41591-024-02955-2.

Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine

Vaccine. 2024 Mar 7; 42(7):1630-1647. doi: 10.1016/j.vaccine.2024.01.087.